Addex Therapeutics Delays Start of Dipraglurant Pivotal Study and Reporting 2019 Full Year Audited Results

 

Addex Therapeutics Delays Start of Dipraglurant Pivotal Study and Reporting 2019 Full Year Audited Results

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. SHARE THIS POST Addex Therapeutics NewsMORE your MARKET VIEW Related Stocks Find News …

More Addex Therapeutics Delays Start of Dipraglurant Pivotal Study and Reporting 2019 Full Year Audited Results Videos

Leave a Reply